ES2054918T3 - Preparacion farmaceutica que se ha de administrar por via oral con una liberacion controlada de las sustancias activas, y un procedimiento para su produccion. - Google Patents
Preparacion farmaceutica que se ha de administrar por via oral con una liberacion controlada de las sustancias activas, y un procedimiento para su produccion.Info
- Publication number
- ES2054918T3 ES2054918T3 ES89106384T ES89106384T ES2054918T3 ES 2054918 T3 ES2054918 T3 ES 2054918T3 ES 89106384 T ES89106384 T ES 89106384T ES 89106384 T ES89106384 T ES 89106384T ES 2054918 T3 ES2054918 T3 ES 2054918T3
- Authority
- ES
- Spain
- Prior art keywords
- pharmaceutical preparation
- administered
- procedure
- production
- controlled release
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
PREPARADO FARMACEUTICO PARA ADMINISTRACION ORAL CON LIBERACION CONTROLADA DE SUSTANCIAS ACTIVAS, COMPUESTO POR UN NUCLEO QUE ESTA COMPUESTO A SU VEZ POR AL MENOS UNA SUSTANCIA FARMACOLOGICAMENTE ACTIVA O POR UN NUCLEO DE MATERIAL FISIOLOGICAMENTE INOFENSIVO QUE ESTA RODEADO POR UNA CAPA CON SUSTANCIAS ACTIVAS CON AL MENOS UNA SUSTANCIA FARMACOLOGICAMENTE ACTIVA, EN SU CASO, UNA MEMBRANA, UNA CAPA ACIDA COMPUESTA POR AL MENOS UN ACIDO FISIOLOGICAMENTE INOFENSIVO Y UNA MEMBRANA DE UNION, COMPUESTA POR UN POLIMERO PH-SENSIBLE Y UN POLIMERO NO SOLUBLE, ASI COMO UN PROCESO PARA SU OBTENCION. LA PREPARACION FARMACEUTICA SE PUEDE APLICAR EN TODAS LAS FORMAS DE FARMACO Y EN LA TERAPIA DE ENFERMEDADES.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3812799A DE3812799A1 (de) | 1988-04-16 | 1988-04-16 | Oral zu verabreichende pharmazeutische zubereitung mit kontrollierter wirkstofffreisetzung und verfahren zu deren herstellung |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2054918T3 true ES2054918T3 (es) | 1994-08-16 |
Family
ID=6352190
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES89106384T Expired - Lifetime ES2054918T3 (es) | 1988-04-16 | 1989-04-11 | Preparacion farmaceutica que se ha de administrar por via oral con una liberacion controlada de las sustancias activas, y un procedimiento para su produccion. |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0338383B1 (es) |
JP (1) | JP2792904B2 (es) |
AT (1) | ATE87201T1 (es) |
DE (2) | DE3812799A1 (es) |
ES (1) | ES2054918T3 (es) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5026559A (en) * | 1989-04-03 | 1991-06-25 | Kinaform Technology, Inc. | Sustained-release pharmaceutical preparation |
CA2032475C (en) * | 1989-05-11 | 1997-12-30 | Heiji Ikushima | Pharmaceutical preparations for oral administration that are adapted to release the drug at appropriate sites in the intestines |
EP0447168A3 (en) * | 1990-03-16 | 1993-01-07 | Yamanouchi Pharmaceutical Co. Ltd. | Long acting granular pharmaceutical composition |
DE4031881C2 (de) * | 1990-10-08 | 1994-02-24 | Sanol Arznei Schwarz Gmbh | Lösungsmittelfreie, oral zu verabreichende pharmazeutische Zubereitung mit verzögerter Wirkstoffreisetzung und Verfahren zu deren Herstellung |
JP3426230B2 (ja) * | 1991-05-20 | 2003-07-14 | アベンティス・ファーマスーティカルズ・インコーポレイテッド | 複数層の制御放出処方剤 |
US5328697A (en) * | 1992-02-10 | 1994-07-12 | Mallinckrodt Veterinary, Inc. | Compositions and processes for the sustained release of drugs |
NZ260408A (en) | 1993-05-10 | 1996-05-28 | Euro Celtique Sa | Controlled release preparation comprising tramadol |
US5891471A (en) | 1993-11-23 | 1999-04-06 | Euro-Celtique, S.A. | Pharmaceutical multiparticulates |
KR100354702B1 (ko) | 1993-11-23 | 2002-12-28 | 유로-셀티크 소시에떼 아노뉨 | 약학조성물의제조방법및서방형조성물 |
US5843480A (en) | 1994-03-14 | 1998-12-01 | Euro-Celtique, S.A. | Controlled release diamorphine formulation |
AT403988B (de) * | 1994-05-18 | 1998-07-27 | Lannacher Heilmittel | Festes orales retardpräparat |
GB9412394D0 (en) | 1994-06-21 | 1994-08-10 | Danbiosyst Uk | Colonic drug delivery composition |
US5965161A (en) | 1994-11-04 | 1999-10-12 | Euro-Celtique, S.A. | Extruded multi-particulates |
SG80553A1 (en) * | 1995-07-20 | 2001-05-22 | Tanabe Seiyaku Co | Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract |
FR2745500B1 (fr) * | 1996-03-04 | 1998-04-03 | Synthelabo | Formulations pharmaceutiques a liberation prolongee contenant de la mizolastine |
AU727753B2 (en) | 1997-01-14 | 2000-12-21 | Lts Lohmann Therapie-Systeme Gmbh | Expandable gastro-retentive therapeutic system with controlled active substance release in the gastro-intestinal tract |
US8545880B2 (en) | 1999-02-26 | 2013-10-01 | Andrx Pharmaceuticals, Llc | Controlled release oral dosage form |
US6210716B1 (en) * | 1999-02-26 | 2001-04-03 | Andrx Pharmaceuticals, Inc. | Controlled release bupropion formulation |
DE19918325A1 (de) | 1999-04-22 | 2000-10-26 | Euro Celtique Sa | Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion |
JP2014529630A (ja) | 2011-09-07 | 2014-11-13 | ザウラー−ブロシュ、ローラント | 哺乳類の消化管における一つあるいは複数の物質の放出制御製剤 |
US10653631B2 (en) | 2011-09-07 | 2020-05-19 | Roland SAUR-BROSCH | Optimal colon targeting technology |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3000979A1 (de) * | 1980-01-12 | 1981-07-23 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue dipyridamol-retardformen und verfahren zu ihrer herstellung |
SE8003805L (sv) * | 1980-05-21 | 1981-11-22 | Haessle Ab | En farmaceutisk beredning med forbettrade utlosningsegenskap |
IT1153487B (it) * | 1982-04-15 | 1987-01-14 | Prophin Lab Spa | Prodotti farmaceutici in forma-ritardo e procedimento per ottenerli |
-
1988
- 1988-04-16 DE DE3812799A patent/DE3812799A1/de not_active Withdrawn
-
1989
- 1989-04-11 ES ES89106384T patent/ES2054918T3/es not_active Expired - Lifetime
- 1989-04-11 AT AT89106384T patent/ATE87201T1/de not_active IP Right Cessation
- 1989-04-11 DE DE8989106384T patent/DE58903856D1/de not_active Expired - Fee Related
- 1989-04-11 EP EP89106384A patent/EP0338383B1/de not_active Expired - Lifetime
- 1989-04-13 JP JP1094297A patent/JP2792904B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0338383B1 (de) | 1993-03-24 |
JP2792904B2 (ja) | 1998-09-03 |
JPH0222222A (ja) | 1990-01-25 |
DE58903856D1 (de) | 1993-04-29 |
EP0338383A3 (en) | 1990-03-28 |
DE3812799A1 (de) | 1989-10-26 |
ATE87201T1 (de) | 1993-04-15 |
EP0338383A2 (de) | 1989-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2054918T3 (es) | Preparacion farmaceutica que se ha de administrar por via oral con una liberacion controlada de las sustancias activas, y un procedimiento para su produccion. | |
MX21218A (es) | Procedimiento para preparar una forma de dosificacion farmaceutica para su administracion oral como solido y producto resultante | |
ATE53176T1 (de) | Pharmazeutische zusammensetzung mit verzoegerter abgabe. | |
NO922232D0 (no) | Fysiologisk aktivt polypeptidholdig farmasoeytisk preparat | |
DE3579068D1 (de) | Arzneimittelenthaltende matrizen fuer einfuehrungen in zonen mit cellularen lesionen. | |
ATE43497T1 (de) | Pharmazeutische formulierung mit gesteuerter absorption. | |
ES2059729T3 (es) | Preparado farmaceutico de liberacion controlada y metodo para producir el mismo. | |
ES2171469T3 (es) | Composicion administrada por via nasal y preparacion que la contiene. | |
ATE68343T1 (de) | Darreichungsform mit kontrollierter freigabe. | |
DE69002604D1 (de) | Pharmazeutische zubereitung mit verzoegerter freisetzung und seine herstellung. | |
IT1245761B (it) | Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale. | |
DK352387A (da) | Farmaceutisk praeparat til oral anvendelse med forsinket virkning og fremgangsmaade til fremstilling deraf | |
PT934058E (pt) | Forma estavel de medicamento para a administracao por via oral com derivados de benzimidazole como substancia activa e processo para a sua producao | |
NO177376C (no) | Fremgangsmåte for fremstilling av en farmasöytisk doseringsform basert på en tampongtrykkmetode | |
IT1153487B (it) | Prodotti farmaceutici in forma-ritardo e procedimento per ottenerli | |
DE3856258T2 (de) | Verfahren zur Herstellung eines Retardpräparates, das Diltiazem in einer einzigen Tagesdosis enthält | |
SE8901003D0 (sv) | Snabbloesliga preparat | |
KR830001816B1 (ko) | 중합형 확산성 매트릭스의 제조방법 | |
ATE124627T1 (de) | Diclofenac-natrium enthaltende pharmazeutische zusammensetzung zur topischen anwendung. | |
SE8501312D0 (sv) | Etoposide oral dosage form | |
RU93031184A (ru) | Препарат для профилактики и лечения заболеваний птиц | |
ATE15139T1 (de) | Phosphonomycine pharmazeutische zusammensetzung in tablettenform. | |
YU46419B (sh) | Postupak za dobivanje novog farmaceutskog preparata koji se sastoji od slojeva koji obezbedjuju kontrolisano oslobadjanje aktivne materije | |
ATE66602T1 (de) | Verwendung von nitrophenylgruppen zur stimulierung der inkorporationsfaehigkeit eines arzneimittels in die empfindlichen wirtszellen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 338383 Country of ref document: ES |